Ravenswood wines making a comeback
The portfolio, returning to the market starting this month, explores the breadth and potential of Zinfandel with wines that are emblematic of their place while offering a distinctive point of view.
The portfolio, returning to the market starting this month, explores the breadth and potential of Zinfandel with wines that are emblematic of their place while offering a distinctive point of view.
Annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programs.
Opening highlights effort to expand U.S. manufacturing through a $1 billion investment.
Dismissal calls into question FTC’s authority to require clinical studies for non-pharmaceutical health products.
"This acquisition is a critical step in driving our Digestive Health platform and solidifying our leadership in the healthcare and OTC CPG industry," says Quest Products CEO.
Women consistently spend nearly 30% more out of pocket on prescriptions than men, totaling $8.5 billion more in 2024 alone.
Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare ecosystem. Ramakrishna is an experienced CEO and global technology leader with more than two decades of technology and business expertise
The RoC 35 Protocol features a comprehensive five-product morning and evening routine.
The Spiced Vanilla Lactation Latte is developed with insights from clinical research and experts.
Waterboy, a hangover hydration solution, is a hit at the Natural Products Expo West in Anaheim.
In his new role, Andersen will lead the strategic direction of the North American Pharmacy Automation Sales teams, including both Inside and Outside Sales, as well as the Clinical Consultants.
"This recognition is a testament to the hard work of our team, strong partnerships with our suppliers, and the trust our consumers and retail partners place in us," says Force Factor CEO.
NovoCare Pharmacy provides direct-to-patient, convenient home shipments of all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients.
CONVERGENCE ‘25, on Oct. 9 – 10, brings industry professionals together for the main business conference, known for its thought-provoking and forward-looking topics, inspiring speakers, and the industry-defining discussions that take place.
Through this collaboration, NIQ Brandbank’s verified product data will integrate seamlessly with RangeMe’s platform.
In 2025, the number of people without commercial insurance coverage for these medications surged significantly. Zepbound saw a 14% increase since 2024, leaving 4.9 million people without coverage, and Ozempic saw a 22% increase, affecting another 1.1 million people.